Presented:
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia
Published in Transfusion Journal, June 2017
Presented:
Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
Published in Springer Nature’s Molecular Diagnosis & Therapy Journal, June 2017
Presented:
An APL Case without a Detectable RARA Gene Rearrangement
Presented at the 2017 Annual Meeting of Association of Genetic Technologists (AGT)
Presented:
BRAF mutation and PD-L1 expression in melanoma: Comparison between multiple PD-L1 IHC clones and BRAF mutation evaluated by FDA-approved kits versus NGS
Abstract published in conjunction with the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO). J Clin Oncol 35, 2017 (suppl; abstr e21050)
Presented:
Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes
Abstract published in conjunction with the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO). J Clin Oncol 35, 2017 (suppl; abstr e14500)
Presented:
Wild-type blocking PCR combined with direct sequencing as a highly sensitive method for detection of low-frequency somatic mutations
Published in Journal of Visualized Experiments, March 2017
Presented:
Correlation Between MET Gene Amplification and TP53 Mutation in Upregulating PD-L1 Expression in EGFR-Wild-Type Lung Cancer
Presented at the 2017 Annual Meeting of American Association for Cancer Research (AACR)
Presented:
Expression of platelet-associated marker CD42b on histoplasma
Presented at the 2017 Annual Meeting of the US and Canadian Academy of Pathology
Presented:
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Published in Oncotarget, February 2017
Presented:
Integrated Analysis of MicroRNA, mRNA, and Protein Expression Utilizing MultiOmyx™ and NanoString™ from Formalin-Fixed Paraffin-Embedded Lung, Head and Neck, Breast, and Melanoma Tumors
Presented at the 2017 Annual Meeting of American Association for Cancer Research (AACR)